# US 2024/0181033 A1 · Nanogel-coated vaccine

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0181033 A1
- Document ID: US20240181033A1
- Status: Published application
- Kind: A1
- Application number: 18/285,148
- Filed: 2022-03-28
- Published: 2024-06-06
- Earliest claimed: 2021-03-30
- Assignees: The University of Tokyo; Hanavax Inc.
- Applicants: The University of Tokyo; HanaVax Inc.
- Inventors: Hiroshi KIYONO; Yoshikazu YUKI
- Web page: https://patentgrep.com/patent/US20240181033A1

## CPC

- A61K 39/12: Viral antigens
- A61K 39/00: Medicinal preparations containing antigens or antibodies (materials for immunoassay G01N33/53)
- A61P 31/12: Antivirals
- A61P 31/14: for RNA viruses
- A61K 2039/543: {intranasal}
- A61K 2039/55555: {Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers}
- A61K 2039/55583: {Polysaccharides}
- A61K 2039/575: {humoral response}
- A61K 2039/64: {characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units}
- C12N 2770/16034: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

It is an object of the present invention to provide: a complex of an antigen that is not encapsulated in a nanogel, and a nanogel; and a vaccine preparation comprising the complex. Specifically, the present invention provides a complex of a nanogel and a vaccine antigen, in which the vaccine antigen is coated with the nanogel

## Claims

### Claim 1

A complex, comprising:
a nanogel, and
a vaccine antigen,
wherein the vaccine antigen is coated with the nanogel.

### Claim 2 (depends on 1)

The complex according to claim 1, wherein a particle diameter of the vaccine antigen is 20 nm or more.

### Claim 3 (depends on 1)

The complex according to claim 1, wherein the vaccine antigen is a substance larger than the nanogel.

### Claim 4 (depends on 1)

The complex according to claim 1, wherein the vaccine antigen is a virus-like particle (VLP), an inactivated virus, a protein molecule with a size of 20 nm or more, or a polymer.

### Claim 5 (depends on 1)

The complex according to claim 1, wherein the vaccine antigen and the nanogel are complexed with each other at a molar ratio of 1:15 to 1:200.

### Claim 6 (depends on 1)

The complex according to claim 1, further comprising an adjuvant.

### Claim 7 (depends on 1)

A vaccine preparation, comprising the complex according to claim 1.

### Claim 8 (depends on 2)

A vaccine preparation, comprising the complex according to claim 2.

### Claim 9 (depends on 3)

A vaccine preparation, comprising the complex according to claim 3.

### Claim 10 (depends on 4)

A vaccine preparation, comprising the complex according to claim 4.
